Ghrelin: a Hypothalamic GH-Releasing Factor in Domestic Fowl (Gallus Domesticus)

Total Page:16

File Type:pdf, Size:1020Kb

Ghrelin: a Hypothalamic GH-Releasing Factor in Domestic Fowl (Gallus Domesticus) 117 Ghrelin: a hypothalamic GH-releasing factor in domestic fowl (Gallus domesticus) S Ahmed and S Harvey Department of Physiology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada (Requests for offprints should be addressed to S Harvey; Email: [email protected]) Abstract Ghrelin, a recently discovered peptide in the mammalian ghrelin. Ghrelin immunoreactivity was also present in hypothalamus and gastrointestinal tract is thought to be the clusters of large ovoid magnocellular cells in the nucleus endogenous ligand for the GH secretagogue (GHS) recep- magnocellularis preopticus pars medialis, nucleus magno- tor and it stimulates GH release in rats and humans. The cellularis preopticus supraopticus and in the chiasma- possibility that ghrelin is present in birds was therefore opticus. Immunoreactivity for ghrelin was restricted to the assessed, since a GHS receptor is present in the chicken cytoplasm of the perikarya and their axonal sprouts. pituitary gland. Immunoreactivity for ghrelin was not seen in any other Although immunoreactive ghrelin is readily detectable hypothalamic nuclei. in the rat stomach and ileum, ghrelin immunoreactivity In a preliminary experiment, circulating GH concen- could not be detected in the chicken proventriculus, trations in conscious immature chicks were promptly stomach, ileum or colon, whereas somatostatin immuno- increased following bolus i.v. administration of human reactivity, in contrast and as expected, was readily ghrelin. The increase in GH concentration (approximately detectable in the chicken gastrointestinal tract. Ghrelin three times that in the controls) was comparable with that immunoreactivity was, however, present in the chicken induced by the same dose (10 µg/kg) of human GH- hypothalamus, although not in the arcuate (infundibular) releasing hormone, although less than that (approximately nucleus, as in rats. Discrete parvocellular cells and neuronal sixfold) induced by thyrotropin-releasing hormone. fibers with ghrelin immunoreactivity were present in the These results demonstrate the presence of a ghrelin-like anterior medial hypothalamus. This immunoreactivity protein in the chicken hypothalamus and suggest that it was specific and completely abolished following the pre- participates in the regulation of GH secretion in birds. absorption of the antibody with an excess of human Journal of Endocrinology (2002) 172, 117–125 Introduction In birds, the control of GH secretion differs from that in mammals, since chicken GHRH has minimal GH- Growth hormone (GH) secretion is regulated by a myriad releasing activity in chickens (Harvey 1999) and because of interacting, multihierarchical factors that dynamically thyrotropin-releasing hormone (TRH) is a potent GH- modify somatotroph function at neural and humeral inter- releasing factor (Harvey 1990). The possibility that ghrelin faces in neurocrine, neuroendocrine, endocrine and para- may participate in GH release in birds was therefore crine ways (Harvey 1995). The hypothalamus is, however, assessed, especially as ghrelin is thought to be the endog- thought to primarily regulate GH release in mammals enous ligand for a GH secretagogue (GHS) receptor through antagonistic interactions between stimulatory identified in chicken pituitary glands (Toogood et al. 1999, (GH-releasing hormone; GHRH) and inhibitory (soma- Gaylinn et al. 2000). tostatin; SRIF) hypophysiotropic-releasing hormones. A third hypothalamic factor, ghrelin, may also be involved (Dieguez & Casanueva 2000, Kojima et al. 2001), since it Materials and Methods is present in the arcuate nucleus of the mouse, rat and human hypothalamus (Kojima et al. 1999, Hosoda et al. Immunocytochemistry 2000a, Korbonits et al. 2001) and is three to five times more potent than GHRH in stimulating GH release in White Leghorns at 4 weeks of age were killed by cervical these species (Kojima et al. 1999, Arvat et al. 2000, Seoane dislocation (with approval from the University of Alberta et al. 2000). It is, however, not known if ghrelin is Health Sciences Animal Welfare Committee) and hypo- involved in GH regulation in other species. thalami were rapidly dissected from the heads, washed in Journal of Endocrinology (2002) 172, 117–125 Online version via http://www.endocrinology.org 0022–0795/02/0172–117 2002 Society for Endocrinology Printed in Great Britain Downloaded from Bioscientifica.com at 09/29/2021 09:50:06AM via free access 118 S AHMED and S HARVEY · GHRH: ghrelin in birds ice-cold phosphate-buffered saline (PBS; pH 7·4) and White Leghorn chicks, in comparison with human collected into freshly prepared paraformaldehyde (4% GHRH1–44 and TRH (Bachem, Torrance, CA, USA). w/v) (Sigma, Mississauga, Ontario, Canada). The hypo- Groups of birds (n=8–16) were given a bolus i.v. injection thalami were removed in one piece, with two parallel cuts of peptide or the 0·9% (w/v) NaCl vehicle (1 ml/kg body 2·0–2·5 mm lateral to the midline, a transverse cut in front weight). Each peptide was administered at a dose of of the preoptic area and the roots of the oculomotor nerves 10 µg/kg, since this is the maximally effective dose of and a cut 4–5 mm deep parallel to the base of the brain TRH and GHRH in chickens (Harvey & Scanes 1984) (MacNamee & Sharp 1989). After overnight fixation, at and is comparable to doses of ghrelin that stimulate GH 4 C, the tissues were dehydrated in a graded series of release in rats (4–20 µg/kg in rats, Hosoda et al. 2000b) alcohol (50% v/v, 15–30 min; 70%, 30–60 min; 95%, and humans (5 µg/kg, Takaya et al. 2000; 33–66 µg/kg, 30–60 min; 100%, 30–60 min) and cleared with hemo-de Peino et al. 2000). Venous blood samples were collected (Fisher Scientific, Edmonton, Alberta, Canada) for from each bird 10 min after injection, at the time of the 30 min. Tissues were then infiltrated with paraffin wax for maximal GH response to TRH and GHRH (Harvey & 24hat60C, under normal atmospheric pressure. Serial Scanes 1984). transverse sections (4–8 µm) were cut with a microtome Following centrifugation and separation, the plasma was and mounted onto treated slides (Fisher Scientific). The stored at20 C prior to GH radioimmunoassay, using sections were cut anterior-dorsally, using co-ordinates NIADD reagents (Bethesda, MD, USA, kindly provided A10·0toA5·6, according to the histological atlas of by Dr A F Parlow). Statistical differences in the results Kuenzel & Masson (1988). Magnocellular nuclei were were determined by analysis of variance. identified according to Yasuda (1980) and Mikami (1985). Immunocytochemical staining was performed with commercial reagents (Vector Laboratories, Burlington, Results CA, USA and Sigma), using an avidin–biotin–peroxidase (ABC) (Hsu et al. 1981) method. Sections were incubated Immunohistochemistry with a specific commercial antibody raised in rabbits against rat ghrelin (RAB-031–31; Phoenix Pharmaceuti- As expected (Kojima et al. 1999, Date et al. 2000a), ghrelin cals, Belmont, CA, USA), with which human ghrelin has immunoreactivity was abundantly present within the 100% cross-reactivity. The primary antibody was diluted X/A-like endocrine cells of the rat stomach (Fig. 1A and 1:500 in 1–5% normal goat serum, overnight, at 4 C. After C). Staining was completely abolished following the pre- incubation, the slides were washed three times for 15 min absorption of the antiserum with human ghrelin (Fig. 1B). in PBS. Sections were then incubated for 1 h at room In contrast, sections of the chicken stomach (and the temperature in biotinylated goat anti-rabbit immuno- proventriculus, ileum and colon) had no ghrelin immu- globulin G (Sigma; 1:200). The slides were washed in PBS noreactivity (data not shown), but were stained for SRIF and incubated in ABC reagent for 1 h at room temperature immunoreactivity (Fig. 1D and F). In the hypothalamus, and washed in PBS. Staining was visualized using the ghrelin immunoreactivity was present in discrete cells in chromogenic substrate diaminobenzidine tetrahydrochlo- the nucleus anterior medialis hypothalami (AM) (Fig. ride (Sigma), which resulted in a brown coloration. The 2A–C and Fig. 4), and was also present in clusters of large specificity of staining was determined by preabsorbing the ovoid cells in the nucleus magnocellularis preopticus pars primary antibody with synthetic human ghrelin (Phoenix medialis (PRM) (Fig. 2A, E and F and Fig. 4), nucleus Pharmaceuticals; 1 mg/ml) for 1 h prior to section incu- magnocellularis preopticus pars supraopticus (PRS) (Fig. bation. Non-specific staining was determined by replacing 3A, E and F and Fig. 4) and in the chiasma opticus (CO) the primary antibody with pre-immune rabbit serum or (Fig. 3A–C and Fig. 4). Immunoreactivity for ghrelin was with PBS or by omission of the secondary antibody. As a restricted to the cytoplasm of the perikarya and their positive control (Kojima et al. 1999), sections of the rat axonal sprouts. Ghrelin staining was lost following the stomach were similarly stained for ghrelin immunoreactiv- preabsorption of the antibody with human ghrelin (Fig. ity. Sections of the chick stomach and gastrointestinal tract 2D and Fig. 3D) and not seen when the ghrelin antibody were similarly stained for SRIF immunoreactivity, using was replaced by normal rabbit serum or PBS (data not shown). Immunoreactivity for ghrelin was not present in an antibody raised in rabbits against SRIF14 (Di Scala- Guenot et al. 1984) at a dilution of 1:200, since SRIF any other hypothalamic nuclei. immunoreactivity has been found throughout the chicken gastrointestinal tract (Denbow 2000). GH-releasing activity Circulating GH concentrations in conscious, immature GH-releasing activity chicks were promptly increased (P<0·001) following the The GH-releasing activity of human ghrelin (Phoenix i.v. administration of human ghrelin (Fig. 5). The increase Pharmaceuticals) was assessed in conscious 4-week-old in GH concentration (approximately three times that in Journal of Endocrinology (2002) 172, 117–125 www.endocrinology.org Downloaded from Bioscientifica.com at 09/29/2021 09:50:06AM via free access GHRH: ghrelin in birds · S AHMED and S HARVEY 119 Figure 1 (A) Ghrelin immunoreactivity in the rat stomach (100).
Recommended publications
  • Adipokines in Breast Milk: an Update Gönül Çatlı1, Nihal Olgaç Dündar2, Bumin Nuri Dündar3
    J Clin Res Pediatr Endocrinol 2014;6(4):192-201 DO I: 10.4274/jcrpe.1531 Review Adipokines in Breast Milk: An Update Gönül Çatlı1, Nihal Olgaç Dündar2, Bumin Nuri Dündar3 1Tepecik Training and Research Hospital, Clinic of Pediatric Endocrinology, İzmir, Turkey 2Katip Çelebi University Faculty of Medicine, Department of Pediatric Neurology, İzmir, Turkey 3Katip Çelebi University Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey Introduction Human breast milk comprises a variety of nutrients, cytokines, peptides, enzymes, cells, immunoglobulins, proteins and steroids specially suited to meet the needs of newborn infants (1,2). Breast milk has benefits on preventing metabolic disorders and chronic diseases and is referred to as “functional food” due to its roles other than nutrition (1,2). It contains 87-90% water and is the main source of water for newborns (3,4,5). In addition, several peptide/protein hormones have recently been identified in human breast milk, including leptin, adiponectin, resistin, obestatin, nesfatin, irisin, adropin, copeptin, ghrelin, pituitary adenylate cyclase-activating polypeptide, apelins, motilin and cholecystokinin (6,7). These breast milk hormones may transiently regulate the activities of various tissues, including endocrine organs until the endocrine system of the neonate begins to function (6). Some of these peptides are secreted in biologically active forms (3). Leptin, ghrelin, insulin, adiponectin, obestatin, resistin, epidermal growth factor, platelet-derived growth factor and insulin-like growth factor 1 are bioactive substances that play roles in energy intake and regulation of body composition (3). However, functions of some ABS TRACT of these peptides in neonatal development are still unknown Epidemiological surveys indicate that nutrition in infancy is implicated in the (4).
    [Show full text]
  • Searching for Novel Peptide Hormones in the Human Genome Olivier Mirabeau
    Searching for novel peptide hormones in the human genome Olivier Mirabeau To cite this version: Olivier Mirabeau. Searching for novel peptide hormones in the human genome. Life Sciences [q-bio]. Université Montpellier II - Sciences et Techniques du Languedoc, 2008. English. tel-00340710 HAL Id: tel-00340710 https://tel.archives-ouvertes.fr/tel-00340710 Submitted on 21 Nov 2008 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE pour obtenir le grade de DOCTEUR DE L'UNIVERSITE MONTPELLIER II Discipline : Biologie Informatique Ecole Doctorale : Sciences chimiques et biologiques pour la santé Formation doctorale : Biologie-Santé Recherche de nouvelles hormones peptidiques codées par le génome humain par Olivier Mirabeau présentée et soutenue publiquement le 30 janvier 2008 JURY M. Hubert Vaudry Rapporteur M. Jean-Philippe Vert Rapporteur Mme Nadia Rosenthal Examinatrice M. Jean Martinez Président M. Olivier Gascuel Directeur M. Cornelius Gross Examinateur Résumé Résumé Cette thèse porte sur la découverte de gènes humains non caractérisés codant pour des précurseurs à hormones peptidiques. Les hormones peptidiques (PH) ont un rôle important dans la plupart des processus physiologiques du corps humain.
    [Show full text]
  • Potential for Gut Peptide-Based Therapy in Postprandial Hypotension
    nutrients Review Potential for Gut Peptide-Based Therapy in Postprandial Hypotension Malcolm J. Borg 1, Cong Xie 1 , Christopher K. Rayner 1, Michael Horowitz 1,2, Karen L. Jones 1,2 and Tongzhi Wu 1,2,* 1 Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide 5000, Australia; [email protected] (M.J.B.); [email protected] (C.X.); [email protected] (C.K.R.); [email protected] (M.H.); [email protected] (K.L.J.) 2 Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide 5000, Australia * Correspondence: [email protected]; Tel.: +61-8-8313-6535 Abstract: Postprandial hypotension (PPH) is an important and under-recognised disorder resulting from inadequate compensatory cardiovascular responses to meal-induced splanchnic blood pool- ing. Current approaches to management are suboptimal. Recent studies have established that the cardiovascular response to a meal is modulated profoundly by gastrointestinal factors, including the type and caloric content of ingested meals, rate of gastric emptying, and small intestinal transit and absorption of nutrients. The small intestine represents the major site of nutrient-gut interactions and associated neurohormonal responses, including secretion of glucagon-like peptide-1, glucose- dependent insulinotropic peptide and somatostatin, which exert pleotropic actions relevant to the postprandial haemodynamic profile. This review summarises knowledge relating to the role of these gut peptides in the cardiovascular response to a meal and their potential application to the management of PPH. Keywords: postprandial hypotension; glucagon-like peptide-1; glucose-dependent insulinotropic Citation: Borg, M.J.; Xie, C.; Rayner, polypeptide; somatostatin; diabetes mellitus; autonomic failure C.K.; Horowitz, M.; Jones, K.L.; Wu, T.
    [Show full text]
  • Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: a Pilot Dose-Ranging Study
    nutrients Article Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study Anne Christin Meyer-Gerspach 1,2,* , Jürgen Drewe 3, Wout Verbeure 4 , Carel W. le Roux 5, Ludmilla Dellatorre-Teixeira 5, Jens F. Rehfeld 6, Jens J. Holst 7 , Bolette Hartmann 7, Jan Tack 4, Ralph Peterli 8, Christoph Beglinger 1,2 and Bettina K. Wölnerhanssen 1,2,* 1 St. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland; [email protected] 2 Faculty of Medicine, University of Basel, 4001 Basel, Switzerland 3 Department of Clinical Pharmacology and Toxicology, University Hospital of Basel, 4001 Basel, Switzerland; [email protected] 4 Translational Research Center for Gastrointestinal Disorders, Catholic University of Leuven, 3000 Leuven, Belgium; [email protected] (W.V.); [email protected] (J.T.) 5 Diabetes Complications Research Centre, Conway Institute University College Dublin, 3444 Dublin, Ireland; [email protected] (C.W.l.R.); [email protected] (L.D.-T.) 6 Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark; [email protected] 7 Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; [email protected] (J.J.H.); [email protected] (B.H.) 8 Department of Surgery, Clarunis, St. Claraspital, 4002 Basel, Switzerland; [email protected] * Correspondence: [email protected] (A.C.M.-G.); [email protected] (B.K.W.); Tel.: +41-61-685-85-85 (A.C.M.-G.
    [Show full text]
  • Endocrine Implications of Obesity and Bariatric Surgery
    Praca Poglądowa/review Endokrynologia Polska DOI: 10.5603/EP.2018.0059 Tom/Volume 69; Numer/Number 5/2018 ISSN 0423–104X Endocrine implications of obesity and bariatric surgery Michał Dyaczyński1, Colin Guy Scanes2, Helena Koziec3, Krystyna Pierzchała-Koziec4 1Siemianowice Śląskie Municipal Hospital, Department of General Surgery, Siemianowice Śląskie, Poland 2Centre in Excellence in Poultry Science, University of Arkansas, Fayetteville, Fayetteville, Arkansas, USA 3Josef Babinski Clinical Hospital in Krakow, Poland 4Department of Animal Physiology and Endocrinology, University of Agriculture in Krakow, Poland Abstract Obesity is a highly prevalent disease in the world associated with the disorders of endocrine system. Recently, it may be concluded that the only effective treatment of obesity remains bariatric surgery. The aim of the review was to compare the concepts of appetite hormonal regulation, reasons of obesity development and bariatric pro- cedures published over the last decade. The reviewed publications had been chosen on the base on: 1. reasons and endocrine consequences of obesity; 2. development of surgery methods from the first bariatric to present and future less aggressive procedures; 3. impact of surgery on the endocrine status of patient. The most serious endocrine disturbances during obesity are dysfunctions of hypothalamic circuits responsible for appetite regulation, insulin resistance, changes in hormones activity and abnormal activity of adipocytes hormones. The currently recommended bariatric surgeries are Roux-en-Y gastric bypass, sleeve gastrectomy and adjustable gastric banding. Bariatric surgical procedures, particularly com- bination of restrictive and malabsorptive, decrease the body weight and eliminate several but not all components of metabolic syndrome. Conclusions: 1. Hunger and satiety are mediated by an interplay of nervous and endocrine signals.
    [Show full text]
  • What Is Pancreatic Polypeptide and What Does It Do?
    What is Pancreatic Polypeptide and what does it do? This document aims to evaluate current understanding of pancreatic polypeptide (PP), a gut hormone with several functions contributing towards the maintenance of energy balance. Successful regulation of energy homeostasis requires sophisticated bidirectional communication between the gastrointestinal tract and central nervous system (CNS; Williams et al. 2000). The coordinated release of numerous gastrointestinal hormones promotes optimal digestion and nutrient absorption (Chaudhri et al., 2008) whilst modulating appetite, meal termination, energy expenditure and metabolism (Suzuki, Jayasena & Bloom, 2011). The Discovery of a Peptide Kimmel et al. (1968) discovered PP whilst purifying insulin from chicken pancreas (Adrian et al., 1976). Subsequent to extraction of avian pancreatic polypeptide (aPP), mammalian homologues bovine (bPP), porcine (pPP), ovine (oPP) and human (hPP), were isolated by Lin and Chance (Kimmel, Hayden & Pollock, 1975). Following extensive observation, various features of this novel peptide witnessed its eventual classification as a hormone (Schwartz, 1983). Molecular Structure PP is a member of the NPY family including neuropeptide Y (NPY) and peptide YY (PYY; Holzer, Reichmann & Farzi, 2012). These biologically active peptides are characterized by a single chain of 36-amino acids and exhibit the same ‘PP-fold’ structure; a hair-pin U-shaped molecule (Suzuki et al., 2011). PP has a molecular weight of 4,240 Da and an isoelectric point between pH6 and 7 (Kimmel et al., 1975), thus carries no electrical charge at neutral pH. Synthesis Like many peptide hormones, PP is derived from a larger precursor of 10,432 Da (Leiter, Keutmann & Goodman, 1984). Isolation of a cDNA construct, synthesized from hPP mRNA, proposed that this precursor, pre-propancreatic polypeptide, comprised 95 residues (Boel et al., 1984) and is processed to produce three products (Leiter et al., 1985); PP, an icosapeptide containing 20-amino acids and a signal peptide (Boel et al., 1984).
    [Show full text]
  • Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model
    Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model Chengbai Liang, Hesheng Luo*, Ying Liu, Jiwang Cao, Hong Xia Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China Abstract Objective: To study the relationship between brain-gut peptides, gastrointestinal hormones and altered motility in a rat model of repetitive water avoidance stress (WAS), which mimics the irritable bowel syndrome (IBS). Methods: Male Wistar rats were submitted daily to 1-h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Plasma hormones were determined using Enzyme Immunoassay Kits. Proximal colonic smooth muscle (PCSM) contractions were studied in an organ bath system. PCSM cells were isolated by enzymatic digestion and IKv and IBKca were recorded by the patch-clamp technique. Results: The number of fecal pellets during 1 h of acute restraint stress and the plasma hormones levels of substance P (SP), thyrotropin-releasing hormone (TRH), motilin (MTL), and cholecystokinin (CCK) in WAS rats were significantly increased compared with SWAS rats, whereas vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP) and corticotropin releasing hormone (CRH) in WAS rats were not significantly changed and peptide YY (PYY) in WAS rats was significantly decreased. Likewise, the amplitudes of spontaneous contractions of PCSM in WAS rats were significantly increased comparing with SWAS rats. The plasma of WAS rats (100 ml) decreased the amplitude of spontaneous contractions of controls. The IKv and IBKCa of PCSMs were significantly decreased in WAS rats compared with SWAS rats and the plasma of WAS rats (100 ml) increased the amplitude of IKv and IBKCa in normal rats.
    [Show full text]
  • Inhibition of Gastrin Release by Secretin Is Mediated by Somatostatin in Cultured Rat Antral Mucosa
    Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa. M M Wolfe, … , G M Reel, J E McGuigan J Clin Invest. 1983;72(5):1586-1593. https://doi.org/10.1172/JCI111117. Research Article Somatostatin-containing cells have been shown to be in close anatomic proximity to gastrin-producing cells in rat antral mucosa. The present studies were directed to examine the effect of secretin on carbachol-stimulated gastrin release and to assess the potential role of somatostatin in mediating this effect. Rat antral mucosa was cultured at 37 degrees C in Krebs-Henseleit buffer, pH 7.4, gassed with 95% O2-5% CO2. After 1 h the culture medium was decanted and mucosal gastrin and somatostatin were extracted. Carbachol (2.5 X 10(-6) M) in the culture medium increased gastrin level in the medium from 14.1 +/- 2.5 to 26.9 +/- 3.0 ng/mg tissue protein (P less than 0.02), and decreased somatostatin-like immunoreactivity in the medium from 1.91 +/- 0.28 to 0.62 +/- 0.12 ng/mg (P less than 0.01) and extracted mucosal somatostatin-like immunoreactivity from 2.60 +/- 0.30 to 1.52 +/- 0.16 ng/mg (P less than 0.001). Rat antral mucosa was then cultured in the presence of secretin to determine its effect on carbachol-stimulated gastrin release. Inclusion of secretin (10(-9)-10(-7) M) inhibited significantly carbachol-stimulated gastrin release into the medium, decreasing gastrin from 26.9 +/- 3.0 to 13.6 +/- 3.2 ng/mg (10(-9) M secretin) (P less than 0.05), to 11.9 +/- 1.7 ng/mg (10(-8) secretin) (P less than 0.02), and to 10.8 +/- 4.0 ng/mg (10(-7) M secretin) (P less than […] Find the latest version: https://jci.me/111117/pdf Inhibition of Gastrin Release by Secretin Is Mediated by Somatostatin in Cultured Rat Antral Mucosa M.
    [Show full text]
  • The Gastrointestinal Cholecystokinin Receptors in Health and Diseases
    Roczniki Akademii Medycznej w Białymstoku · Vol. 50, 2005 · TheAnnales gastrointestinal Academiae cholecystokinin Medicae Bialostocensis receptors in health and diseases 21 The gastrointestinal cholecystokinin receptors in health and diseases Morisset J* Service de Gastroentérologie, Université de Sherbrooke, Canada Key words: cholecystokinin, gastrin, cholecystokinin recep- gene in different species, their localization and the results of tors, pancreas. their specific occupation under normal and pathological states. Introduction Cholecystokinin Over the years, cholecystokinin (CCK) has been accepted as A. Molecular forms the gastrointestinal hormone mainly responsible for the control Shortly after his discovery of CCK-33 in pig intestine [1], of gallbladder contraction, pancreatic enzyme secretion, growth Mutt purified the slightly larger form CCK-39 from the same of the pancreatic gland and gut motility. On the contrary, its sis- species’ intestine [5]. Later on, smaller and larger molecules ter hormone gastrin is recognized to regulate gastric acid secre- were isolated from several species’ brain and intestine. CCK-58, tion and proliferation of the acid secreting portion of the gastric 8, 5 and 4 were found in porcine brain [6] whereas the molecular mucosae as well as that of the upper intestine and colon. forms 58, 39, 33, 25, 18, 8, 7 and 5 were all identified in dog These two hormones share the same carboxy-terminal pen- intestine [7,8]. Some of these same peptides were also identified tapeptide amide sequence but differ in their sulfation sites on in bovine intestine, 39 and 33, in rat intestine, 58, 22, 8 and in the active C-terminal portion of their molecule; indeed, gastrin guinea pig intestine, 22 and 8 [9-11].
    [Show full text]
  • Gastrointestinal Hormone Actions in the Central Regulation of Energy Metabolism: Potential Sensory Roles for the Circumventricular Organs
    International Journal of Obesity (2009) 33, S16–S21 & 2009 Macmillan Publishers Limited All rights reserved 0307-0565/09 $32.00 www.nature.com/ijo REVIEW Gastrointestinal hormone actions in the central regulation of energy metabolism: potential sensory roles for the circumventricular organs TD Hoyda, PM Smith and AV Ferguson Department of Physiology, Queen’s University, Kingston, Ontario, Canada A variety of circulating signals provide essential information to the central nervous system (CNS) regarding nutritional status. The gastrointestinal system produces many such molecules that are now known to have profound effects on feeding behavior and the control of metabolism as a consequence of their ability to regulate the neural circuitry involved in metabolic homeostasis. Although many of these substances have been suggested to directly access such brain centers, their lipophobic characteristics suggest that alternative mechanisms should be considered. In this paper, we consider one such alternative, namely, that a specialized group of CNS structures collectively known as the sensory circumventricular organs (CVOs), which are not protected by the normal blood–brain barrier, may play important roles in such blood to brain communications. Specifically, we review a developing literature that shows receptors for, and functional actions of, gastrointestinal hormones such as amylin, cholecystokinin, ghrelin and peptide YY in the area postrema and subfornical organ. Collectively, these observations suggest potentially significant roles for the sensory CVOs in the regulation of energy balance. International Journal of Obesity (2009) 33, S16–S21; doi:10.1038/ijo.2009.11 Keywords: amylin; ghrelin; peptide YY; regulation of food intake; adipokines; circumventricular organs Introduction appreciation of the regulatory circuitry controlling the integration of feeding and metabolism.
    [Show full text]
  • Distribution of the Gut Hormones in the Primate Intestinal Tract
    Gut: first published as 10.1136/gut.20.8.653 on 1 August 1979. Downloaded from Gut, 1979, 20, 653-659 Distribution of the gut hormones in the primate intestinal tract M. G. BRYANT AND S. R. BLOOM From the Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London SUMMARY Reliable and specific radioimmunoassays have been developed for the gut hormones secretin, gastrin, cholecystokinin, pancreatic glucagon, VIP, GIP, motilin, and enteroglucagon. Using these assays, the relative pattern of distribution of the gut hormones has been determined using the same bowel extracts for all measurements. VIP occurred in high concentration in all regions of the bowel, whereas secretin, GIP, motilin, and CCK were predominantly localised in the proximal small intestine. Pancreatic glucagon was almost exclusively confined to the pancreas. Like VIP, enteroglucagon also exhibited a wide pattern of distribution but was maximal in the ileum. The acid ethanol extraction method that was used was found to be unsuitable for gastrin. On gel chromatography of the extracts, motilin and VIP eluted as single molecular species in identical position to the pure porcine peptides. CCK, pancreatic glucagon, enteroglucagon and GIP were all multiform. Over the last decade the development of radio- peptide throughout the primate intestinal tract immunoassays for the gut hormones has allowed using the same bowel extracts for all measurements. their quantitative measurement both in plasma and in tissue. Although this has prompted several investi- Methods http://gut.bmj.com/ gations to determine the normal distribution of these hormones in different species (Unger et al., 1961; EXTRACTION Bloom and Bryant, 1973; Reeder et al., 1973; The complete intestinal tract was removed after Rehfeld et al., 1975; Bloom et al., 1975; O'Dorisio brief anaesthesia from four healthy baboons and et al., 1976), no comprehensive study has been three monkeys (Macaca Iris) all of whom had been undertaken in the primate.
    [Show full text]
  • Anorexia Nervosa: a Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan 
    Int. J. Med. Sci. 2011, 8 679 Ivyspring International Publisher International Journal of Medical Sciences 2011; 8(8):679-703 Review Anorexia Nervosa: A Unified Neurological Perspective Tasneem Fatema Hasan, Hunaid Hasan Mahatma Gandhi Mission’s Medical College, Aurangabad, Maharashtra, India Corresponding author: [email protected] or [email protected]. 1345 Daniel Creek Road, Mississau- ga, Ontario, L5V1V3, Canada. © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2011.05.03; Accepted: 2011.09.19; Published: 2011.10.22 Abstract The roles of corticotrophin-releasing factor (CRF), opioid peptides, leptin and ghrelin in anorexia nervosa (AN) were discussed in this paper. CRF is the key mediator of the hypo- thalamo-pituitary-adrenal (HPA) axis and also acts at various other parts of the brain, such as the limbic system and the peripheral nervous system. CRF action is mediated through the CRF1 and CRF2 receptors, with both HPA axis-dependent and HPA axis-independent ac- tions, where the latter shows nil involvement of the autonomic nervous system. CRF1 re- ceptors mediate both the HPA axis-dependent and independent pathways through CRF, while the CRF2 receptors exclusively mediate the HPA axis-independent pathways through uro- cortin. Opioid peptides are involved in the adaptation and regulation of energy intake and utilization through reward-related behavior. Opioids play a role in the addictive component of AN, as described by the “auto-addiction opioids theory”.
    [Show full text]